Addex Therapeutics logo

Addex Therapeutics

ADXN | NASDAQ
Chart Builder DCF Calculator
$3.83
-$0.23 (-5.67%)
At close: Nov 16, 2026, 4:00 PM ET
$3.72
-$0.11 (-2.87%)
After-hours: Nov 16, 2026, 7:27 PM ET
-5.67%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
30
+1.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #790/1021 (Top 77%)

Key Statistics

Market Data

Market Cap $5.57M
1D Range
3.60 3.99
52W Range
2.65 8.99

Valuation (TTM)

PE -0.54
PB 2.36
EV/EBITDA -0.67

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $30.00
Loading financial charts...

Profile

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting ...

Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Feb 12, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.